GNS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.271400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.351400E-01
Normal-vs-Stage2
8.094400E-01
Normal-vs-Stage3
1.569790E-01
Normal-vs-Stage4
9.887800E-01
Stage1-vs-Stage2
5.335200E-01
Stage1-vs-Stage3
4.554200E-02
Stage1-vs-Stage4
3.497000E-01
Stage2-vs-Stage3
2.079800E-01
Stage2-vs-Stage4
7.690600E-01
Stage3-vs-Stage4
4.482400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.989800E-01
Normal-vs-AfricanAmerican
6.389600E-01
Normal-vs-Asian
4.917200E-01
Caucasian-vs-AfricanAmerican
2.798600E-01
Caucasian-vs-Asian
5.633200E-01
AfricanAmerican-vs-Asian
1.220440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.534400E-01
Normal-vs-Female
8.955800E-01
Male-vs-Female
6.650400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.341000E-01
Normal-vs-Age(41-60Yrs)
7.867800E-01
Normal-vs-Age(61-80Yrs)
7.218200E-01
Normal-vs-Age(81-100Yrs)
3.926000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.140200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.434200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.894400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.983920E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.517800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.561600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.825200E-01
Normal-vs-Daily Drinker
3.511400E-01
Normal-vs-Weekly Drinker
7.424000E-01
Normal-vs-Occasional Drinker
9.922200E-01
Normal-vs-Social Drinker
9.696400E-01
Non Drinker-vs-Daily Drinker
8.073000E-01
Non Drinker-vs-Weekly Drinker
1.979560E-01
Non Drinker-vs-Occasional Drinker
5.405800E-02
Non Drinker-vs-Social Drinker
1.012200E-01
Daily Drinker-vs-Weekly Drinker
3.084600E-01
Daily Drinker-vs-Occasional Drinker
1.109230E-01
Daily Drinker-vs-Social Drinker
1.794810E-01
Weekly Drinker-vs-Occasional Drinker
5.879800E-01
Weekly Drinker-vs-Social Drinker
6.891400E-01
Occasional Drinker-vs-Social Drinker
9.297600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.641600E-01
Normal-vs-Grade 2
7.265000E-01
Normal-vs-Grade 3
4.846200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.523400E-01
Grade 1-vs-Grade 3
7.875600E-01
Grade 1-vs-Grade 4
3.641600E-01
Grade 2-vs-Grade 3
6.865600E-01
Grade 2-vs-Grade 4
7.265000E-01
Grade 3-vs-Grade 4
4.846200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.404400E-01
Normal-vs-NonDiabetic
5.942400E-01
Diabetic-vs-NonDiabetic
4.902000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.706400E-01
Normal-vs-NoPancreatitis
7.922000E-01
Pancreatitis-vs-NoPancreatitis
1.301790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.980800E-01
Normal-vs-N1
8.459200E-01
N0-vs-N1
6.610200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.248200E-01
Normal-vs-TP53-NonMutant
5.922200E-01
TP53-Mutant-vs-TP53-NonMutant
7.787000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
